A recent retrospective study in patients with glioblastoma multiforme found that OCT3 protein level was significantly lower in tumor tissue than in the tumor-adjacent normal brain tissue and that patients with low OCT3 expression had a worse prognosis and outcome [111]. The gene discussed is SLC22A3; the disease is glioblastoma.